|
|
||||||||
-adrenergic blockade
1 Department of Kinesiology and Applied Physiology, University of Colorado, Boulder, Colorado 80309; 2 Palo Alto Veterans Affairs Health Care System, Palo Alto, California 94304; and 3 University of Colorado Health Sciences Center, Denver, Colorado 80262
Interleukin-6
(IL-6), an important cytokine involved in a number of biological
processes, is consistently elevated during periods of stress. The
mechanisms responsible for the induction of IL-6 under these conditions
remain uncertain. This study examined the effect of
-adrenergic
blockade on the IL-6 response to acute and chronic high-altitude
exposure in women both at rest and during exercise. Sixteen healthy,
eumenorrheic women (aged 23.2 ± 1.4 yr) participated in the
study. Subjects received either
-adrenergic blockade (prazosin, 3 mg/day) or a placebo in a double-blinded, randomized fashion.
Subjects participated in submaximal exercise tests at sea level and on
days 1 and 12 at altitude (4,300 m). Resting
plasma and 24-h urine samples were collected throughout the duration of
the study. At sea level, no differences were found at rest for plasma
IL-6 between groups (1.5 ± 0.2 and 1.2 ± 0.3 pg/ml for
placebo and blocked groups, respectively). On acute ascent to altitude,
IL-6 levels increased significantly in both groups compared with
sea-level values (57 and 84% for placebo and blocked groups,
respectively). After 12 days of acclimatization, IL-6 levels remained
elevated for placebo subjects; however, they returned to sea-level
values in the blocked group.
-Adrenergic blockade significantly
lowered the IL-6 response to exercise both at sea level (46%) and at
altitude (42%) compared with placebo. A significant correlation
(P = 0.004) between resting IL-6 and urinary
norepinephrine excretion rates was found over the course of time while
at altitude. In conclusion, the results indicate a role for
-adrenergic regulation of the IL-6 response to the stress of both
short-term moderate-intensity exercise and hypoxia.
hypoxia; catecholamines; norepinephrine; epinephrine; cytokines
This article has been cited by other articles:
![]() |
A. H. Miller and C. L. Raison Immune System Contributions to the Pathophysiology of Depression Focus, January 1, 2008; 6(1): 36 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chouker, F. Demetz, A. Martignoni, L. Smith, F. Setzer, A. Bauer, J. Holzl, K. Peter, F. Christ, and M. Thiel Strenuous physical exercise inhibits granulocyte activation induced by high altitude J Appl Physiol, February 1, 2005; 98(2): 640 - 647. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, and C. H. Lang Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E809 - E817. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bailey, G.-R. Kleger, M. Holzgraefe, P. E. Ballmer, and P. Bartsch Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness J Appl Physiol, April 1, 2004; 96(4): 1459 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, and C. H. Lang Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1153 - R1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ronsen, T. Lea, R. Bahr, and B. K. Pedersen Enhanced plasma IL-6 and IL-1ra responses to repeated vs. single bouts of prolonged cycling in elite athletes J Appl Physiol, June 1, 2002; 92(6): 2547 - 2553. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |